A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
Status:
Not yet recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
This is a phase I, multicenter, open-label study. The study will investigate the safety,
tolerability, PK, and preliminary efficacy of TY-2699a on locally advanced or metastatic
solid tumors.